Scientists have recently found a highly accurate way to predict the best treatment for patients with meningioma based on patterns of gene expression in their tumors. In this Better Edge podcast episode, Stephen Magill, MD, PhD, of Northwestern Medicine Neurological Surgery, discusses this innovative test that could change treatment for one in three patients with meningioma.
